Mehdi Gholam‐Rezaee

Author

Mehdi Gholam‐Rezaee

Also Known As

Gholamrezaee, M., M Gholam-Rezaee, M. Gholam, M. Gholam-Rezaee, M. Gholamrezaee, M. Mehdi Gholam, Mehdi Gholam, Mehdi Gholam-Rezaee, Mehdi Gholamrezaee, Mehdi Gholam‐Rezaee

Publications

1.9K

Citations

H-Index

Concepts

All Affiliations

University of Lausanne University of Geneva National Institute of Mental Health University Hospital of Geneva University Hospital of Lausanne

About

Mehdi Gholam‐Rezaee is an author at University of Lausanne specializing in medicine, psychiatry, and psychopathology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	14	16	817
2	Social Sciences	6	6	336
3	Health Sciences	4	4	235
4	Engineering	1	1	46
5	Public Health	1	1	15

Mehdi Gholam‐Rezaee

Publications

1.8K

Citations

H-Index

Page 1

	Year	Citations
N-acetylcysteine in a Double-Blind Randomized Placebo-Controlled Trial: Toward Biomarker-Guided Treatment in Early Psychosis Philippe Conus, Larry J. Seidman, Margot Fournier, Schizophrenia Bulletin NeuropsychologyPsychotropic MedicationValid BiomarkersToward Biomarker-guided TreatmentPsychopharmacology	2017	161
Prospective associations of depression subtypes with cardio-metabolic risk factors in the general population Aurélie M. Lasserre, Marie‐Pierre F. Strippoli, Jennifer Glaus, Molecular Psychiatry ObesityMetabolic SyndromePsychiatryCardiometabolic RiskMood Symptom	2016	110
Interobserver agreement and validity of bedside ‘positive signs’ for functional weakness, sensory and gait disorders in conversion disorder: a pilot study Corinna Daum, Fulvia Gheorghita, Marianna Spatola, Journal of Neurology Neurosurgery & Psychiatry	2014	101
Mental disorders in offspring of parents with bipolar and major depressive disorders Caroline L. Vandeleur, Stéphane Rothen, Mehdi Gholam‐Rezaee, Bipolar Disorders	2012	96
Importance of Early Weight Changes to Predict Long-Term Weight Gain During Psychotropic Drug Treatment Frederik Vandenberghe, Mehdi Gholam‐Rezaee, Núria Saigí-Morgui, The Journal of Clinical Psychiatry	2015	94
Associations between mood, anxiety or substance use disorders and inflammatory markers after adjustment for multiple covariates in a population-based study Jennifer Glaus, Caroline L. Vandeleur, Roland von Känel, Journal of Psychiatric Research Psychological Co-morbiditiesPopulation-based StudyPsychopathologySubstance UsePsychiatry	2014	75
Atypical depression and alcohol misuse are related to the cardiovascular risk in the general population Jennifer Glaus, Caroline L. Vandeleur, Mehdi Gholam‐Rezaee, Acta Psychiatrica Scandinavica	2012	71
The bidirectional relationship between anxiety disorders and circulating levels of inflammatory markers: Results from a large longitudinal population-based study Jennifer Glaus, Roland von Känel, Aurélie M. Lasserre, Depression and Anxiety Psychological Co-morbiditiesMental HealthComorbid Psychiatric DisorderInflammatory MarkerStress Biomarkers	2017	67
The specificity of the familial aggregation of early-onset bipolar disorder : A controlled 10-year follow-up study of offspring of parents with mood disorders Martin Preisig, Marie‐Pierre F. Strippoli, Enrique Castelao, Journal of Affective Disorders Family MedicineEarly-onset Bipolar DisorderPsychiatryMood SymptomDepression	2015	66
Decreasing body mass index is associated with cerebrospinal fluid markers of Alzheimer's pathology in MCI and mild dementia Jules Mathys, Mehdi Gholam‐Rezaee, Hugues Henry, Experimental Gerontology Cerebrospinal Fluid MarkersAlzheimer's DiseaseDementiaBody Mass IndexVascular Dementia	2017	59

Page 1